|
|
 |
|
Viewing report
|
|
|
|
Cardiovascular Devices Pipeline Analysis: Innovation and Consolidation Intensify Competition February 22
Decision Resources, Inc, Feb 2005, Pages: 89
The treatment of cardiovascular disease (CVD) represents a large and sustainable market growth opportunity for cardiovascular device companies.
In 2003, the worldwide cardiovascular device market was estimated at $16.6 billion. High-growth opportunities within the cardiovascular market include cardiac rhythm management (CRM) and coronary stents--primarily drug-eluting stents (DES).
These two product segments, which represent approximately two-thirds of the cardiovascular device market, will continue to grow throughout the decade and into the future as a result of many factors.
These factors include the continued expansion of indications appropriate for use of CRM products, the launch of improved CRM and DES products that allow patients to be treated earlier in the disease process and thereby allow access to larger patient populations, and the lack of viable competing alternative pharmaceutical or other treatments.
This report examines the key devices driving the adoption of new cardiovascular procedures.
The focus is on leading companies and device categories that address cardiovascular disease, specifically coronary disease.
We also discuss the potential impact of emerging therapeutic trends and products.
|
|
|
|
